Q1Medicare.com
Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community
  • ☰ MENU
  • Home
  • Contact
  • MAPD
  • PDP
  • 2017
  • FAQs
  • Latest Medicare News

Brand-Name Drug Patent Expiration Search

Patent Expiration Search
..
Expiration Years: through   
Brand Drugs: through   
Sort By: Date     Brand     Generic
Quick links (2012-2013): A-C  D-F  G-J  K-M  N-Q  R-T  U-W  X-Z 
::2011 PDP-Finder (Drug Only Plans)
::Compare 2010 & 2011 Plans
::2011 PDP-DrugFinder (Formulary Drug Search)
There are 27 Patent Expirations Found.
Patents expiring between 2012 and 2013 for the Letters R through T
Patent Expiration Information
Brand Name Generic Name Expiration* Common Use Manufacturer
Singulair® montelukast 2012-02 Asthma, allergy symptoms MERCK
Revatio® sildenafil 2012-03 Pulmonary arterial hypertension PFIZER
SEROQUEL XR® (Pediatric) QUETIAPINE FUMARATE 2012-03 ASTRAZENECA
SEROQUEL® (Pediatric) QUETIAPINE FUMARATE 2012-03 ASTRAZENECA
TAXOTERE® DOCETAXEL 2012-07 SANOFI AVENTIS US
SINGULAIR® (Pediatric) MONTELUKAST SODIUM 2012-08 MERCK
RAPAMUNE® (Pediatric) SIROLIMUS 2012-10 WYETH PHARMS INC
SPRIX® KETOROLAC TROMETHAMINE 2012-10 LUITPOLD
TASMAR® TOLCAPONE 2012-12 VALEANT PHARM INTL
STARLIX® NATEGLINIDE 2013-01 NOVARTIS
TAXOTERE® (Pediatric) DOCETAXEL 2013-01 SANOFI AVENTIS US
TRAMADOL HYDROCHLORIDE® TRAMADOL HYDROCHLORIDE 2013-03 SHIONOGI INC
RAPLON® RAPACURONIUM BROMIDE 2013-04 ORGANON USA INC
Rilutek® riluzole 2013-06 Amyotrophic lateral sclerosis SANOFI AVENTIS US
TIAZAC® DILTIAZEM HYDROCHLORIDE 2013-06 VALEANT INTL
TYGACIL® TIGECYCLINE 2013-06 WYETH PHARMS INC
Rapamune® sirolimus 2013-07 Prevent organ rejection WYETH PHARMS INC
Renagel® sevelamer 2013-08 Chronic kidney disease GENZYME
Renvela® sevelamer 2013-08 Chronic kidney disease GENZYME
Brand Name Generic Name Expiration* Common Use Manufacturer
TRAVATAN Z® TRAVOPROST 2013-08 ALCON PHARMS LTD
Travatan® travoprost ophthalmic solution 2013-08 Glaucoma, ocular hypertension ALCON PHARMS LTD
REZULIN® TROGLITAZONE 2013-09 PFIZER PHARMS
SIMCOR® NIACIN; SIMVASTATIN 2013-09 ABBOTT
SYMLIN® PRAMLINTIDE ACETATE 2013-09 AMYLIN
RAXAR® GREPAFLOXACIN HYDROCHLORIDE 2013-10 OTSUKA
TECHNESCAN MAG3® TECHNETIUM TC-99M MERTIATIDE KIT 2013-11 MALLINCKRODT
SOLAGE® MEQUINOL; TRETINOIN 2013-12 AQUA PHARMS
*Note: The data contained in this chart is for informational purposes only. The expiration dates are subject to change due to litigation, agreements, additional patents, exclusivities, and other factors.

Click the +1 button if you have found this page useful:  

Advertisement
Medicare Supplements
fill the gaps in your
Original Medicare
1. Select Your State:
» Medicare Supplement FAQs

Advertisement





.

Advertisement



Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.